|
1- octadecanoyl- 2- [(9Z,11Z,13Z,15Z,17Z,19E)- docosahexaenoyl]- sn- glycero- 3- phosphocholine |
|
CHEBI:84830 |
|
1-octadecanoyl-2-[(9Z,11Z,13Z,15Z,17Z,19E)-docosahexaenoyl]-sn-glycero-3-phosphocholine |
|
A phosphatidylcholine 40:6 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (9Z,11Z,13Z,15Z,17Z,19E)-docosahexaenoyl respectively. |
|
![](images/goldenstar.gif) ![](images/goldenstar.gif)
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C48H84NO8P/c1- 6- 8- 10- 12- 14- 16- 18- 20- 22- 23- 24- 25- 27- 29- 31- 33- 35- 37- 39- 41- 48(51) 57- 46(45- 56- 58(52,53) 55- 43- 42- 49(3,4) 5) 44- 54- 47(50) 40- 38- 36- 34- 32- 30- 28- 26- 21- 19- 17- 15- 13- 11- 9- 7- 2/h8,10,12,14,16,18,20,22- 25,27,46H,6- 7,9,11,13,15,17,19,21,26,28- 45H2,1- 5H3/b10- 8+,14- 12- ,18- 16- ,22- 20- ,24- 23- ,27- 25- /t46- /m1/s1 |
YZEGHVUBSYVNCN-CVCSLSNUSA-N |
CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C=C\C=C/C=C\C=C/C=C/CC |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via phosphatidylcholine 40:6 )
|
|
View more via ChEBI Ontology
Outgoing
|
1- octadecanoyl- 2- [(9Z,11Z,13Z,15Z,17Z,19E)- docosahexaenoyl]- sn- glycero- 3- phosphocholine
(CHEBI:84830)
has functional parent
octadecanoic acid
(CHEBI:28842)
1- octadecanoyl- 2- [(9Z,11Z,13Z,15Z,17Z,19E)- docosahexaenoyl]- sn- glycero- 3- phosphocholine
(CHEBI:84830)
has role
mouse metabolite
(CHEBI:75771)
1- octadecanoyl- 2- [(9Z,11Z,13Z,15Z,17Z,19E)- docosahexaenoyl]- sn- glycero- 3- phosphocholine
(CHEBI:84830)
is a
phosphatidylcholine 40:6
(CHEBI:64431)
|
|
(2R)- 2- [(9Z,11Z,13Z,15Z,17Z,19E)- docosa- 9,11,13,15,17,19- hexaenoyloxy]- 3- (octadecanoyloxy)propyl 2- (trimethylammonio)ethyl phosphate
|
PC(18:0/22:6(9Z,11Z,13Z,15Z,17Z,19))
|
LIPID MAPS
|
PC(18:0/22:6)
|
LIPID MAPS
|
|